eIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma

Fang, C; Xie, HS; Zhao, J; Wang, WC; Hou, H; Zhang, B; Zhou, DC; Geng, XP

Geng, XP (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.

ANTI-CANCER DRUGS, 2021; 32 (8): 822

Abstract

The clinical efficacy of sorafenib in hepatocellular carcinoma (HCC) is disappointing due to its low response rate and high rates of adverse effects. ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索